Cargando…
Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors
Extensive desmoplasia is a hallmark of pancreatic ductal adenocarcinoma (PDAC), which frequently associates with treatment resistance. Recent findings indicate that a combination of photodynamic therapy and the multi-kinase inhibitor cabozantinib achieved local tumor control and a significant decrea...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352584/ https://www.ncbi.nlm.nih.gov/pubmed/32485915 http://dx.doi.org/10.3390/cancers12061401 |
_version_ | 1783557672106196992 |
---|---|
author | Broekgaarden, Mans Alkhateeb, Ahmed Bano, Shazia Bulin, Anne-Laure Obaid, Girgis Rizvi, Imran Hasan, Tayyaba |
author_facet | Broekgaarden, Mans Alkhateeb, Ahmed Bano, Shazia Bulin, Anne-Laure Obaid, Girgis Rizvi, Imran Hasan, Tayyaba |
author_sort | Broekgaarden, Mans |
collection | PubMed |
description | Extensive desmoplasia is a hallmark of pancreatic ductal adenocarcinoma (PDAC), which frequently associates with treatment resistance. Recent findings indicate that a combination of photodynamic therapy and the multi-kinase inhibitor cabozantinib achieved local tumor control and a significant decrease in tumor metastases in preclinical PDAC models, but the underlying therapeutic mechanisms remain unclear. This study elucidates the molecular basis of this multi-agent regimen, focusing on the role of MET signaling. Since MET activation stems from its interaction with hepatocyte growth factor (HGF), which is typically secreted by fibroblasts, we developed heterotypic PDAC microtumor models that recapitulate these interactions. In these models, MET signaling can be constitutively activated through paracrine and autocrine mechanisms. Photodynamic therapy caused significant elevations in HGF secretion by fibroblasts, suggesting it plays a complex role in the modulation of the paracrine HGF–MET signaling cascade in desmoplastic tumors. Blocking MET phosphorylation with adjuvant cabozantinib caused a significant improvement in photodynamic therapy efficacy, most notably by elevating spheroid necrosis at low radiant exposures. These findings highlight that adjuvant photodynamic therapy can augment chemotherapy efficacies, and potentially achieve improved management of desmoplastic PDAC in a more tolerable manner. |
format | Online Article Text |
id | pubmed-7352584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73525842020-07-15 Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors Broekgaarden, Mans Alkhateeb, Ahmed Bano, Shazia Bulin, Anne-Laure Obaid, Girgis Rizvi, Imran Hasan, Tayyaba Cancers (Basel) Article Extensive desmoplasia is a hallmark of pancreatic ductal adenocarcinoma (PDAC), which frequently associates with treatment resistance. Recent findings indicate that a combination of photodynamic therapy and the multi-kinase inhibitor cabozantinib achieved local tumor control and a significant decrease in tumor metastases in preclinical PDAC models, but the underlying therapeutic mechanisms remain unclear. This study elucidates the molecular basis of this multi-agent regimen, focusing on the role of MET signaling. Since MET activation stems from its interaction with hepatocyte growth factor (HGF), which is typically secreted by fibroblasts, we developed heterotypic PDAC microtumor models that recapitulate these interactions. In these models, MET signaling can be constitutively activated through paracrine and autocrine mechanisms. Photodynamic therapy caused significant elevations in HGF secretion by fibroblasts, suggesting it plays a complex role in the modulation of the paracrine HGF–MET signaling cascade in desmoplastic tumors. Blocking MET phosphorylation with adjuvant cabozantinib caused a significant improvement in photodynamic therapy efficacy, most notably by elevating spheroid necrosis at low radiant exposures. These findings highlight that adjuvant photodynamic therapy can augment chemotherapy efficacies, and potentially achieve improved management of desmoplastic PDAC in a more tolerable manner. MDPI 2020-05-29 /pmc/articles/PMC7352584/ /pubmed/32485915 http://dx.doi.org/10.3390/cancers12061401 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Broekgaarden, Mans Alkhateeb, Ahmed Bano, Shazia Bulin, Anne-Laure Obaid, Girgis Rizvi, Imran Hasan, Tayyaba Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors |
title | Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors |
title_full | Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors |
title_fullStr | Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors |
title_full_unstemmed | Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors |
title_short | Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors |
title_sort | cabozantinib inhibits photodynamic therapy-induced auto- and paracrine met signaling in heterotypic pancreatic microtumors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352584/ https://www.ncbi.nlm.nih.gov/pubmed/32485915 http://dx.doi.org/10.3390/cancers12061401 |
work_keys_str_mv | AT broekgaardenmans cabozantinibinhibitsphotodynamictherapyinducedautoandparacrinemetsignalinginheterotypicpancreaticmicrotumors AT alkhateebahmed cabozantinibinhibitsphotodynamictherapyinducedautoandparacrinemetsignalinginheterotypicpancreaticmicrotumors AT banoshazia cabozantinibinhibitsphotodynamictherapyinducedautoandparacrinemetsignalinginheterotypicpancreaticmicrotumors AT bulinannelaure cabozantinibinhibitsphotodynamictherapyinducedautoandparacrinemetsignalinginheterotypicpancreaticmicrotumors AT obaidgirgis cabozantinibinhibitsphotodynamictherapyinducedautoandparacrinemetsignalinginheterotypicpancreaticmicrotumors AT rizviimran cabozantinibinhibitsphotodynamictherapyinducedautoandparacrinemetsignalinginheterotypicpancreaticmicrotumors AT hasantayyaba cabozantinibinhibitsphotodynamictherapyinducedautoandparacrinemetsignalinginheterotypicpancreaticmicrotumors |